Latest Financial Instruments News

Intelligent Investor Equity Growth Fund returned to a $4.769 million operating profit in the year to 30 June 2026, after recording a $242,000 loss a year earlier. The improvement came with sharply higher distributions, but substantial redemptions reduced net assets and the fund faces an unresolved change of investment-manager ownership.

Colchester Emerging Markets Bond Fund returned 4.96% net for the year, outperforming its benchmark by nearly three percentage points as net assets climbed to $254.7 million. The fund has since added an ETF class to the ASX, opening a new distribution channel for its emerging-markets strategy.

Colchester Global Government Bond Fund delivered returns of 2.32% to 2.48% across its existing classes in FY2026, ahead of its 2.16% benchmark. The audited report also records the launch of an ETF class on the ASX, while profit before finance costs fell sharply as market gains reversed.

WCM Quality Global Growth Fund delivered a positive 16.87% return for the year, although it lagged its global benchmark and reported sharply lower distributions. Its longer-term record remains ahead of the benchmark, leaving investors weighing recent relative weakness against a new income-focused policy.

Global X EURO STOXX 50 ETF delivered a higher annual profit and a sharp increase in net assets as investor applications accelerated. The audited report also highlights the fund’s sizeable exposure to European equities and euro-Australian dollar movements.

Global X Defence Tech ETF reported a $13.84 million loss for the year ended 30 June 2026, reversing a $7.50 million profit a year earlier. The result was driven by $14.48 million in net losses on investments and foreign exchange, even as investor applications lifted net assets to $112.56 million.

Global X Australian Bank Credit ETF more than doubled its net assets to $184 million in the year to 30 June 2026, while profit rose to $6.9 million. The audited report also shows a larger exposure to BBB-rated debt and a sharp increase in distributions payable.

Perennial Better Future Active ETF will be voluntarily wound up after a $2.601 million loss and a sharp contraction in its unitholder base. The fund’s Responsible Entity says it is unlikely to achieve the scale needed to operate economically, with the process expected to finish in financial year 2027.

Ziller Global Fund Active ETF reported a $1.77 million comprehensive loss for the year ended 30 June 2026, despite net assets rising to $10.9 million. The fund’s ASX debut, $10.2 million of applications and enlarged distribution came alongside a sharp investment loss.

Global X FANG+ ETF reported a sharp decline in annual profit, while its net asset value fell by more than 10% after 30 June as underlying technology stocks weakened. The audited fund still grew net assets to AUD1.606 billion and declared a 235.84 cents-per-unit distribution.

Global X China Tech ETF reported an AUD15.727 million profit for the year ended 30 June 2026, powered by gains in listed Chinese technology investments. But the fund disclosed that its net asset value has since fallen by more than 10%, leaving the audited result looking increasingly historical.

Global X S&P Biotech ETF (ASX:CURE) reported a AUD22.601 million profit for the year to 30 June 2026, reversing the prior year’s AUD2.863 million loss. The turnaround was driven overwhelmingly by gains in listed biotech securities and foreign exchange, rather than recurring income.